Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunomonitoring of Tacrolimus in healthy volunteers

Trial Profile

Immunomonitoring of Tacrolimus in healthy volunteers

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 04 Oct 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Allergic conjunctivitis; Atopic dermatitis; Coronary artery restenosis; Eye disorders; Graft-versus-host disease; Interstitial lung diseases; Intestinal transplant rejection; Lupus nephritis; Myasthenia gravis; Open-angle glaucoma; Psoriasis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 Sep 2018 Status changed from active, no longer recruiting to completed.
    • 02 Sep 2018 Status changed from recruiting to active, no longer recruiting.
    • 08 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top